Evidence map›Paper›PMID 12562791›Full record

ArticleJournal of bacteriology2003

In vitro and in vivo functional activity of Chlamydia MurA, a UDP-N-acetylglucosamine enolpyruvyl transferase involved in peptidoglycan synthesis and fosfomycin resistance.

Andrea J McCoy, Robin C Sandlin, Anthony T Maurelli

Open access · greenAbstract read
In one paragraph

Article in Journal of bacteriology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 116 citations in OpenAlex.

  1. Article
  2. Article
  3. Collateral Sensitivity to Fosfomycin of Tobramycin-Resistant Mutants ofInternational journal of molecular sciences · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Fosfomycin Resistance Evolutionary Pathways ofInternational journal of molecular sciences · 2022
    Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Consensus by Chinese Expert Panel onChinese medical journal · 2017
    Article
  17. Article
  18. Chlamydia prevalence in Polish pig herds.Epidemiology and infection · 2016
    Article
  19. Article
  20. Fosfomycin.Clinical microbiology reviews · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Andrea J McCoyDepartment of Microbiology and Immunology, F. Edward Hébert School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814-4799, USA.
Robin C Sandlin
Anthony T Maurelli
Uniformed Services University of the Health Sciences · US

Funding

MOLECULAR GENETIC ANALYSIS OF CHLAMYDIA PATHOGENICITYR01AI044033 · NIAID · UNIVERSITY OF FLORIDA · PI MAURELLI, ANTHONY T · 1999 to 2016
$3.9M
Molecular Genetic Analysis of Chlamydia PathogenicityR56AI044033 · NIAID · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI MAURELLI, ANTHONY T · 2012 to 2012
$363k
Molecular Genetic Analysis of Chlamydia PathogenicityR21AI044033 · NIAID · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI MAURELLI, ANTHONY T · 2004 to 2004
$301k
NIAID NIH HHS AI44033NIAID NIH HHS R01 AI044033NIAID NIH HHS R21 AI044033NIAID NIH HHS R56 AI044033
6 · The paper itself

Abstract

Organisms of Chlamydia spp. are obligate intracellular, gram-negative bacteria with a dimorphic developmental cycle that takes place entirely within a membrane-bound vacuole termed an inclusion. The chlamydial anomaly refers to the fact that cell wall-active antibiotics inhibit Chlamydia growth and peptidoglycan (PG) synthesis genes are present in the genome, yet there is no biochemical evidence for synthesis of PG. In this work, we undertook a genetics-based approach to reevaluate the chlamydial anomaly by characterizing MurA, a UDP-N-acetylglucosamine enolpyruvyl transferase that catalyzes the first committed step of PG synthesis. The murA gene from Chlamydia trachomatis serovar L2 was cloned and placed under the control of the arabinose-inducible, glucose-repressible ara promoter and transformed into Escherichia coli. After transduction of a lethal DeltamurA mutation into the strain, viability of the E. coli strain became dependent upon expression of the C. trachomatis murA. DNA sequence analysis of murA from C. trachomatis predicted a cysteine-to-aspartate change in a key residue within the active site of MurA. In E. coli, the same mutation has previously been shown to cause resistance to fosfomycin, a potent antibiotic that specifically targets MurA. In vitro activity of the chlamydial MurA was resistant to high levels of fosfomycin. Growth of C. trachomatis was also resistant to fosfomycin. Moreover, fosfomycin resistance was imparted to the E. coli strain expressing the chlamydial murA. Conversion of C. trachomatis elementary bodies to reticulate bodies and cell division are correlated with expression of murA mRNA. mRNA from murB, the second enzymatic reaction in the PG pathway, was also detected during C. trachomatis infection. Our findings, as well as work from other groups, suggest that a functional PG pathway exists in Chlamydia spp. We propose that chlamydial PG is essential for progression through the developmental cycle as well as for cell division. Elucidating the existence of PG in Chlamydia spp. is of significance for the development of novel antibiotics targeting the chlamydial cell wall.

Indexed as

Alkyl and Aryl TransferasesAnti-Bacterial AgentsChlamydia trachomatisCloning, MolecularDrug Resistance, BacterialEscherichia coliFosfomycinGene Expression Regulation, BacterialGenetic Complementation TestHumansMolecular Sequence DataPeptidoglycanReverse Transcriptase Polymerase Chain ReactionSequence Analysis, DNAAlkyl and Aryl TransferasesAnti-Bacterial AgentsFosfomycinPeptidoglycanUDP-N-acetylglucosamine 1-carboxyvinyltransferase

Identifiers

PMID12562791
PMCPMC142877
OpenAlexW2111413785

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.